相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Guanidinylated Polymyxins as Outer Membrane Permeabilizers Capable of Potentiating Rifampicin, Erythromycin, Ceftazidime and Aztreonam against Gram-Negative Bacteria
Danzel Marie Ramirez et al.
ANTIBIOTICS-BASEL (2022)
Amino Acid Substitution Ser83Ile in GyrA of DNA Gyrases Confers High-Level Quinolone Resistance to Nontyphoidal Salmonella Without Loss of Supercoiling Activity
Kentaro Koide et al.
MICROBIAL DRUG RESISTANCE (2021)
Permeability barriers of Gram-negative pathogens
Helen I. Zgurskaya et al.
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES (2020)
WQ-3810 inhibits DNA gyrase activity in ofloxacin-resistant Mycobacterium leprae
Jong-Hoon Park et al.
JOURNAL OF INFECTION AND CHEMOTHERAPY (2020)
Quinolones: Mechanism, Lethality and Their Contributions to Antibiotic Resistance
Natassja G. Bush et al.
MOLECULES (2020)
WQ-3810 exerts high inhibitory effect on quinolone-resistant DNA gyrase of Salmonella Typhimurium
Kentaro Koide et al.
BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY (2019)
Efflux pump inhibitors for bacterial pathogens: From bench to bedside
Atin Sharma et al.
INDIAN JOURNAL OF MEDICAL RESEARCH (2019)
A review of Salmonella enterica with particular focus on the pathogenicity and virulence factors, host specificity and antimicrobial resistance including multidrug resistance
Saleh Mohammed Jajere
VETERINARY WORLD (2019)
Clinical review of delafloxacin: a novel anionic fluoroquinolone
Bryan T. Mogle et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2018)
Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis
Evelina Tacconelli et al.
LANCET INFECTIOUS DISEASES (2018)
Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017
Spencer L. G. James et al.
LANCET (2018)
Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the Global Burden of Disease Study 2017
Gregory A. Roth et al.
LANCET (2018)
Fluoroquinolone resistance in Salmonella: insights by whole-genome sequencing
Wim L. Cuypers et al.
MICROBIAL GENOMICS (2018)
The European Union summary report on trends and sources of zoonoses, zoonotic agents and food-borne outbreaks in 2017
EFSA JOURNAL (2018)
Quinolone Resistance Determinants of Clinical Salmonella Enteritidis in Thailand
Fuangfa Utrarachkij et al.
MICROBIAL DRUG RESISTANCE (2017)
Emergence of Resistance Mutations in Salmonella enterica Serovar Typhi Against Fluoroquinolones
Takashi Matono et al.
OPEN FORUM INFECTIOUS DISEASES (2017)
Whole-Genome Sequencing of Drug-Resistant Salmonella enterica Isolates from Dairy Cattle and Humans in New York and Washington States Reveals Source and Geographic Associations
Laura M. Carroll et al.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2017)
In Vitro Activity of Delafloxacin against Contemporary Bacterial Pathogens from the United States and Europe, 2014
M. A. Pfaller et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Amino acid substitutions in GyrA affect quinolone susceptibility in Salmonella typhimurium
Siriporn Kongsoi et al.
DRUG TESTING AND ANALYSIS (2016)
Whole-Genome Sequencing for Detecting Antimicrobial Resistance in Nontyphoidal Salmonella
Patrick F. McDermott et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
A novel ciprofloxacin-resistant subclade of H58 Salmonella Typhi is associated with fluoroquinolone treatment failure
Duy Pham Thanh et al.
ELIFE (2016)
Origins of the Quinolone Class of Antibacterials: An Expanded Discovery Story
Gregory S. Bisacchi
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Salmonella enterica: Survival, Colonization, and Virulence Differences among Serovars
A. Andino et al.
TheScientificWorldJOURNAL (2015)
Salmonella enterica: Survival, Colonization, and Virulence Differences among Serovars
A. Andino et al.
Scientific World Journal (2015)
In vitro activity of WQ-3810, a novel fluoroquinolone, against multidrug-resistant and fluoroquinolone-resistant pathogens
Daichi Kazamori et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2014)
Impact of the E540V Amino Acid Substitution in GyrB of Mycobacterium tuberculosis on Quinolone Resistance
Hyun Kim et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Structural basis of quinolone inhibition of type IIA topoisomerases and target-mediated resistance
Alexandre Wohlkonig et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2010)
Outer membrane permeability and antibiotic resistance
Anne H. Delcour
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2009)
Quinolone-mediated bacterial death
Karl Drlica et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Identification of metabolites produced from N-phenylpiperazine by Mycobacterium spp
M. D. Adjei et al.
JOURNAL OF INDUSTRIAL MICROBIOLOGY & BIOTECHNOLOGY (2007)
Mycobacterium tuberculosis DNA gyrase:: Interaction with quinolones and correlation with antimycobacterial drug activity
A Aubry et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
In vitro and bactericidal activities of ABT-492, a novel fluoroquinolone, against gram-positive and gram-negative organisms
LS Almer et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
In vitro antibacterial potency and spectrum of ABT-492, a new fluoroquinolone
AM Nilius et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
The quinolones: decades of development and use
AM Emmerson et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2003)
Quinolone molecular structure-activity relationships: What we have learned about improving antimicrobial activity
LR Peterson
CLINICAL INFECTIOUS DISEASES (2001)
Interaction between DNA gyrase and quinolones:: Effects of alanine mutations at GyrA subunit residues Ser83 and Asp87
FM Barnard et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
Type II topoisomerases as targets for quinolone antibacterials: turning Dr. Jekyll into Mr. Hyde
VE Anderson et al.
CURRENT PHARMACEUTICAL DESIGN (2001)
分享论文
